Barclays
BIOA

Barclays’s BioAmber Inc. BIOA Stock Holding History

Barclays’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-31
Closed – – 6661
2015
Q4 		$0 Sell
31
-60
-66% -$452 ﹤0.01% 6982
2015
Q3 		$0 Buy
+91
New +$601 ﹤0.01% 7225
2015
Q2 		– Sell
-100
Closed -$1K – 7345
2015
Q1 		$1K Buy
100
+15
+18% +$132 ﹤0.01% 7017
2014
Q4 		$1K Sell
85
-686
-89% -$6.24K ﹤0.01% 7204
2014
Q3 		$7K Buy
771
+312
+68% +$3.65K ﹤0.01% 7071
2014
Q2 		$4K Buy
+459
New +$4.74K ﹤0.01% 7238
2014
Q1 		– Sell
-389
Closed -$3K – 7823
2013
Q4 		$3K Buy
389
+362
+1,341% +$2.48K ﹤0.01% 7310
2013
Q3 		$0 Sell
27
-1,312
-98% -$7.47K ﹤0.01% 7750
2013
Q2 		$9K Buy
+1,339
New +$9.96K ﹤0.01% 7192

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Barclays's BIOA Position: Q1 2016 in Review

Barclays sold out of BioAmber Inc. (BIOA) in Q1 2016, closing a stake of 31 shares.

Barclays first reported a position in BIOA in Q2 2013 and held it in 9 quarters. The position peaked at $9K in Q2 2013. 31 funds tracked by Wall St. Rank hold BIOA as of Q1 2016.

  • Barclays reported no remaining BioAmber Inc. position as of Q1 2016 after selling out during the quarter.
  • Barclays sold 31 BioAmber Inc. shares in Q1 2016.
  • Barclays first reported a position in BioAmber Inc. in Q2 2013 and held it in 9 quarters.
  • Barclays's BioAmber Inc. position peaked at $9K in Q2 2013.
  • 31 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2016.

Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.